Specialty Solutions Spotlight: Using Quality Physical Therapy First for Low Back Pain Helps Reduce Costs and Improves Outcomes
2 MIN READ
The U.S. health care system wastes an estimated $750 billion annually, with $200 billion attributed to overuse or unnecessary services. In workers' compensation, physical therapy can account for up to 20% of medical costs, making it crucial to ensure appropriateness and quality to manage claim costs effectively.
Demystifying the Nuances of Specialty Bill Review Regulations
Navigate the complexities of Specialty Bill Review Regulations with Enlyte. Tune into our podcast where Trevor Davis, our Director of Regulatory Affairs, offers insights into dispute management, regulatory changes, and our strategic efforts to shape the landscape.
Gauging the Impact of High-Impact Drugs in Workers’ Comp
Unlock the Full Potential of State-Certified Managed Care Plans
1 MIN READ
This guide will inform you of the advantages of a state-certified managed care plan and help you choose the best option for your unique needs.
Seven Technology Features in Utilization Review Software to Control Medical Costs
3 MIN READ
Discover essential features of utilization review software that can help combat rising medical costs in workers' compensation.
Technology Meets Empathy in Modern Telephonic Case Management
5 MIN READ
Discover how early intervention telephonic case management (TCM) integrates clinical expertise, AI, and technology to enhance workers' compensation claims, promote faster recoveries, and build trust with injured employees.
Enlyte Pharmacists Discuss a Changing Workers’ Comp Pharmacy Landscape
4 MIN READ
Workers' compensation pharmacy is constantly evolving, from tackling the opioid crisis, to the rise of compounding pharmacies, to the pandemic. Amidst these changes, pharmacy benefit managers must constantly evolve to address an array of industry changes. In our final Enlytening Conversation our pharmacists discuss how changes within the industry as a whole including physician shortages, digital therapeutics, biopsychosocial approaches, new drug treatments, and much more are driving the need for constant planning and innovation to stay a step ahead in this ever-changing landscape.